Active Biotech AB (ACTI) — Net Asset Quality Index
Active Biotech AB (ACTI) has a Net Asset Quality Index of 81.1% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of Skr58.20 Million minus total liabilities of Skr11.00 Million yields net assets of Skr47.20 Million. A higher index indicates a stronger, lower-leverage balance sheet. Read debt load of Active Biotech AB for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Active Biotech AB Net Asset Quality Index Over Time (2000–2025)
This chart shows how Active Biotech AB's Net Asset Quality Index has evolved across 26 annual periods from 2000 to 2025. As of March 2026, the index stands at 81.1%, representing net assets of Skr47.20 Million against total assets of Skr58.20 Million SEK. For live market cap and overall valuation, see ACTI company net worth.
Annual Net Asset Quality Index for Active Biotech AB (2000–2025)
The table below presents the year-by-year Net Asset Quality Index for Active Biotech AB from 2000 to 2025, covering 26 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check ACTI strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (SEK) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 79.2% | Skr55.60 Million | Skr70.20 Million | Skr14.60 Million | ▲ +5.0 pp |
| 2024 | 74.2% | Skr32.07 Million | Skr43.20 Million | Skr11.13 Million | ▲ +4.6 pp |
| 2023 | 69.6% | Skr30.67 Million | Skr44.05 Million | Skr13.38 Million | ▲ +2.0 pp |
| 2022 | 67.7% | Skr34.51 Million | Skr51.01 Million | Skr16.49 Million | ▼ -14.5 pp |
| 2021 | 82.2% | Skr46.67 Million | Skr56.80 Million | Skr10.13 Million | ▲ +13.4 pp |
| 2020 | 68.8% | Skr22.11 Million | Skr32.16 Million | Skr10.04 Million | ▼ -11.6 pp |
| 2019 | 80.3% | Skr53.78 Million | Skr66.95 Million | Skr13.17 Million | ▲ +51.3 pp |
| 2018 | 29.1% | Skr87.92 Million | Skr302.43 Million | Skr214.52 Million | ▲ +3.5 pp |
| 2017 | 25.6% | Skr77.68 Million | Skr303.81 Million | Skr226.14 Million | ▼ -18.6 pp |
| 2016 | 44.2% | Skr182.56 Million | Skr412.88 Million | Skr230.32 Million | ▲ +4.0 pp |
| 2015 | 40.2% | Skr180.60 Million | Skr449.44 Million | Skr268.84 Million | ▼ -15.9 pp |
| 2014 | 56.1% | Skr405.31 Million | Skr722.52 Million | Skr317.21 Million | ▲ +3.3 pp |
| 2013 | 52.8% | Skr405.41 Million | Skr767.81 Million | Skr362.40 Million | ▲ +4.0 pp |
| 2012 | 48.8% | Skr339.92 Million | Skr696.74 Million | Skr356.82 Million | ▼ -9.7 pp |
| 2011 | 58.5% | Skr501.99 Million | Skr858.52 Million | Skr356.53 Million | ▲ +22.3 pp |
| 2010 | 36.1% | Skr181.76 Million | Skr503.10 Million | Skr321.34 Million | ▼ -1.7 pp |
| 2009 | 37.8% | Skr188.64 Million | Skr498.50 Million | Skr309.86 Million | ▲ +3.2 pp |
| 2008 | 34.6% | Skr163.61 Million | Skr472.95 Million | Skr309.34 Million | ▼ -4.1 pp |
| 2007 | 38.7% | Skr189.57 Million | Skr489.54 Million | Skr299.97 Million | ▲ +25.7 pp |
| 2006 | 13.1% | Skr60.36 Million | Skr462.40 Million | Skr402.04 Million | ▼ -18.1 pp |
| 2005 | 31.1% | Skr176.81 Million | Skr567.86 Million | Skr391.05 Million | ▼ -20.7 pp |
| 2004 | 51.9% | Skr162.30 Million | Skr312.89 Million | Skr150.59 Million | ▼ -32.0 pp |
| 2003 | 83.8% | Skr289.58 Million | Skr345.40 Million | Skr55.82 Million | ▲ +2.5 pp |
| 2002 | 81.3% | Skr380.27 Million | Skr467.50 Million | Skr87.24 Million | ▼ -9.4 pp |
| 2001 | 90.8% | Skr678.78 Million | Skr747.74 Million | Skr68.96 Million | ▲ +16.4 pp |
| 2000 | 74.3% | Skr646.03 Million | Skr868.95 Million | Skr222.92 Million | — |